Carbon nanospheres mediated nuclear delivery of SMAR1 protein (DNA binding domain) controls breast tumor in mice model

被引：3

作者：

Bhagat, Prasad N. ^{[1
]}

Jadhav, Sachin H. ^{[1
]}

Chattopadhyay, Samit ^{[2
,3
]}

Paknikar, Kishore M. ^{[1
]}

机构：

[1] Agharkar Res Inst, GG Agarkar Rd, Pune 411004, Maharashtra, India

[2] Natl Ctr Cell Sci, SP Pune Univ Campus,Ganeshkhind Rd, Pune 411007, Maharashtra, India

[3] Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, India

来源：

NANOMEDICINE | 2018年 / 13卷 / 04期

关键词：

breast cancer; carbon nanospheres; DNA binding domain; PET; SMAR1; MESOPOROUS SILICA NANOPARTICLES; SOLID LIPID NANOPARTICLES; CANCER-THERAPY; IN-VIVO; P53; PEPTIDE; GROWTH; CELLS; THERAPEUTICS; METASTASIS;

D O I：

10.2217/nnm-2017-0298

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aim: To investigate anticancer activity of the DNA binding domain of SMAR1 (His 5) in vitro and in vivo. Materials & methods: His 5 was conjugated to hydrothermally synthesized carbon nanospheres (CNs). Anticancer activity of CNs-His 5 was evaluated in vitro and in vivo. Results: CNs-His 5 significantly reduced cyclin D1 levels in MDA-MB-231 cells. Tumor bearing Balb/c mice injected with CNs-His 5 showed approximately 62% tumor regression and significantly reduced (18)FDG uptake. Caspases assay and IHC staining confirmed tumor growth inhibition, which could be attributed to apoptotic, antiproliferative and antiangiogenic activities of His 5. Conclusion: DNA binding domain of the SMAR1 protein (His 5) has potent anticancer activity and its CNs mediated delivery could control breast tumor in mice model.

引用

页码：353 / 372

页数：20

共 56 条

[31] Caspase Functions in Cell Death and Disease [J].

McIlwain, David R. ;

Berger, Thorsten ;

Mak, Tak W. .

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2013, 5 (04) :1-28

[32] Impact of Excipient Interactions on Solid Dosage Form Stability [J].

Narang, Ajit S. ;

Desai, Divyakant ;

Badawy, Sherif .

PHARMACEUTICAL RESEARCH, 2012, 29 (10) :2660-2683

[33] Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer [J].

Parvani, Jenny G. ;

Gujrati, Maneesh D. ;

Mack, Margaret A. ;

Schiemann, William P. ;

Lu, Zheng-Rong .

CANCER RESEARCH, 2015, 75 (11) :2316-2325

[34] Bacteria in cancer therapy: a novel experimental strategy [J].

Patyar, S. ;

Joshi, R. ;

Byrav, D. S. Prasad ;

Prakash, A. ;

Medhi, B. ;

Das, B. K. .

JOURNAL OF BIOMEDICAL SCIENCE, 2010, 17

[35] Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex [J].

Rampalli, S ;

Pavithra, L ;

Bhatt, A ;

Kundu, TK ;

Chattopadhyay, S .

MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (19) :8415-8429

[36]

Rosenholm JM, 2012, NANOMEDICINE-UK, V7, P111, DOI [10.2217/nnm.11.166, 10.2217/NNM.11.166]

[37] Antibody therapy of cancer [J].

Scott, Andrew M. ;

Wolchok, Jedd D. ;

Old, Lloyd J. .

NATURE REVIEWS CANCER, 2012, 12 (04) :278-287

[38] Intrinsically Fluorescent Carbon Nanospheres as a Nuclear Targeting Vector: Delivery of Membrane-Impermeable Molecule to Modulate Gene Expression In Vivo [J].

Selvi, B. Ruthrotha ;

Jagadeesan, Dinesh ;

Suma, B. S. ;

Nagashankar, G. ;

Arif, M. ;

Balasubramanyam, K. ;

Eswaramoorthy, M. ;

Kundu, Tapas K. .

NANO LETTERS, 2008, 8 (10) :3182-3188

[39] Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression [J].

Shi, Sanjun ;

Han, Lu ;

Deng, Li ;

Zhang, Yanling ;

Shen, Hongxin ;

Gong, Tao ;

Zhang, Zhirong ;

Sun, Xun .

JOURNAL OF CONTROLLED RELEASE, 2014, 194 :228-237

[40] The relationship between FDG uptake in PET scans and biological behavior in breast cancer. [J].

Shimoda W. ;

Hayashi M. ;

Murakami K. ;

Oyama T. ;

Sunagawa M. .

Breast Cancer, 2007, 14 (3) :260-268

← 1 2 3 4 5 6 →